Former Goldman Sachs CEO Lloyd Blankfein sees speculative elements across markets for stocks and bonds. Blankfein, a billionaire who served as Goldman’s CEO from 2006 to 2018, said Thursday on Squawk Box that low interest rates were essentially creating free money for big institutional investors. After keeping rates low for years after the 2008 financial
0 Comments
Spencer Platt | Getty Images News | Getty Images Even with election year volatility and no stimulus package in sight, it looks like the stars are aligning for a fourth quarter stock market rally. Technical analysts say they see underlying trends that signal strength and further gains, including broader groups of stocks participating, like small
0 Comments
High-net-worth individuals tend to have more complex financial needs than most retail consumers. That’s why private banks offer a wide swath of services under one roof, from investment management to trust and estate planning. Wealthy clients are typically assigned a dedicated private banker (a.k.a. relationship manager), who is a single point of contact. Key Takeaways Most of these
0 Comments
Earlier this year, Hertz Global (NYSE:HTZ) was one of the names that rose to infamy/notoriety as the Robinhood crowd became enamored by tumbling, low-priced stocks in the hopes of catching rallies, however brief. Source: Eric Glenn/Shutterstock.com Indeed, there were some occasions when this risky strategy paid off. There was stretch in March when HTZ stock
0 Comments
We are witnessing a new age of medicine with the increasing acceptance of people’s right to what goes inside their bodies. Over the past decade, several researches have come out supporting psychedelic-inspired medicines in treating conditions including addiction, depression, and ADHD. Hence, the “shroom boom” is here and is likely to propel psychedelic stocks as
0 Comments
Nelson Peltz speaking at the 2019 Delivering Alpha conference in New York on Sept. 19, 2019. Adam Jeffery | CNBC Company: Invesco Ltd. (IVZ) Business: Independent investment management company. Invesco provides a range of investment capabilities and outcomes, which are delivered through a set of investment vehicles, to help clients achieve their investment objectives. Its
0 Comments
Middle-market senior and secured lending specialist Prospect Capital (NASDAQ:PSEC) isn’t a company that generates red-hot buzz on social media. You won’t find heated conversations about PSEC stock. But that should be just fine for more risk-averse investors. Source: Shutterstock The shares are also accessible to amateur and professional traders alike. That’s because PSEC stock trades
0 Comments
Artificial intelligence is set to be a massive trend in the coming decades. As such, investors are looking to find companies that can profit from the trend. But for several reasons, finding quality AI stocks is harder than it might seem. First, some of the leaders in artificial intelligence are massive businesses, which means AI
0 Comments
CNBC’s Jim Cramer on Thursday highlighted multiple parts of the market where he sees stock prices rising and can continue to rise, whether lawmakers in Washington agree to another round of stimulus spending or not. American consumers and small businesses, grappling with double-digit unemployment and a pandemic-induced downturn, are waiting to see if lawmakers will
0 Comments
Japan has become one of the top 10 most popular destinations for U.S. students studying abroad. According to the President of the Institute of International Education, Dr. Allen E. Goodman, “International experience is one of the most important components of a 21st-century education, and study abroad should be viewed as an essential element of a college degree.”
0 Comments
Tracey Ryniec and Kevin Cook take a look at two highly ranked stocks.’ Alteryx: https://www.zacks.com/stock/quote/AYX?cid=CS-YOUTUBE-FT-VID InMode: https://www.zacks.com/stock/quote/INMD?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
0 Comments
In 2020, many drug stocks have behaved like pot stocks did in 2018. Investors have paid huge premiums on sales for even the promise of a novel coronavirus treatment or vaccine. But if you’re looking for value, consider Pfizer (NYSE:PFE). You can still buy PFE stock at a reasonable price. Source: Manuel Esteban / Shutterstock.com
0 Comments
For investors, there’s playing the lottery. And then there’s Sorrento Therapeutics (NASDAQ:SRNE). The unassuming biotech firm initially made headlines in May when it suggested it had a “cure” for coronavirus. SRNE stock initially spiked 140% before investors saw through the misstatement. Source: Shutterstock The company then saw its second wave of interest in August after
0 Comments
With the Las Vegas Strip continuing to rebound and MGM (NYSE:MGM) receiving a roughly $1 billion investment from IAC (NASDAQ:IAC), the outlook of MGM stock has improved. Source: Michael Neil Thomas / Shutterstock.com Additionally, following the widespread introduction of a successful vaccine for the novel coronavirus, MGM is set benefit from a huge amount of
0 Comments